UPDATE: JP Morgan Downgrades Celgene On Less Upside, Remains Optimistic On Growth

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

In a report published Thursday, JP Morgan analyst Geoff Meacham downgraded

27% profit every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Celgene

(NASDAQ: CELG) from Overweight to Neutral and lowered the price target from $180.00 to $170.00.Despite the company's solid fundamentals, Meacham noted less upside to shares. The analyst wrote, “The change isn't reflective of a new fundamental concern; indeed, Celgene's growth rate is expected to be robust over the next few years.”Shares of Celgene closed at $154.30 on Wednesday. The stock is currently trading down 0.73 percent in Thursday's pre-market trading.